Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the Drugs Controller......
It is safe to consume milk from cattle infected by Lumpy Skin Disease, which is a non-zoonotic infection and not transmissible from animals to humans, according to a senior official of Indian......
Bharat Biotech is targeting one billion doses in annual production. This is from its own sites alone, reports Sohini Das. India’s first indigenous Covid-19 vaccine to be approved, Bharat......
This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is......
500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.Sohini Das reports. IMAGE: Union Health Minister Harsh Vardhan shows......
FII stance, progress of monsoon, crude oil and rupee movement are likely to dictate the trend on the bourses Benchmark share indices ended flat, amid a volatile trading session, after......